Albireo Pharma logo
Albireo Pharma ALBO

Quarterly report 2022-Q3
added 11-08-2022

report update icon

Albireo Pharma Operating Cycle 2011-2026 | ALBO

Annual Operating Cycle Albireo Pharma

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
40.8 - - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
40.8 40.8 40.8

Quarterly Operating Cycle Albireo Pharma

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
- 409 248 423 - 37 - - - - - - - - - - - - - - - 251 45.6 - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
423 37 236

Operating Cycle of other stocks in the Biotechnology industry

Issuer Operating Cycle Price % 24h Market Cap Country
Precigen Precigen
PGEN
91.2 $ 3.1 -0.96 % $ 758 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
115 - 5.93 % $ 314 M canadaCanada
I-Mab I-Mab
IMAB
271 - - $ 866 M chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
12.8 - - $ 40.3 B usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
245 - -18.52 % $ 27.3 M britainBritain
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
32 - -1.52 % $ 24.7 M usaUSA
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
237 $ 19.57 1.77 % $ 915 M usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
186 - -10.17 % $ 12.2 K usaUSA
Aptinyx Aptinyx
APTX
46.9 - -39.0 % $ 4.57 M usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
394 - -24.86 % $ 820 K usaUSA
Acasti Pharma Acasti Pharma
ACST
1.97 - 4.01 % $ 150 M canadaCanada
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
104 - - - russiaRussia
Advaxis Advaxis
ADXS
88.1 - -9.65 % $ 45.9 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
61.7 - - $ 7.46 M israelIsrael
BeiGene, Ltd. BeiGene, Ltd.
BGNE
52.6 - 0.49 % $ 251 B cayman-islandsCayman-islands
bluebird bio bluebird bio
BLUE
127 - - $ 546 M usaUSA
BioDelivery Sciences International BioDelivery Sciences International
BDSI
436 - -4.8 % $ 255 M usaUSA
Cara Therapeutics Cara Therapeutics
CARA
52.4 - -3.03 % $ 260 M usaUSA
ChemoCentryx ChemoCentryx
CCXI
3.1 - - $ 3.74 B usaUSA
Avid Bioservices Avid Bioservices
CDMO
148 - - $ 789 M usaUSA
CRISPR Therapeutics AG CRISPR Therapeutics AG
CRSP
1.1 K $ 47.09 1.42 % $ 4.23 B schweizSchweiz
Arbutus Biopharma Corporation Arbutus Biopharma Corporation
ABUS
50 $ 4.53 5.1 % $ 868 M canadaCanada
AIkido Pharma AIkido Pharma
AIKI
17.9 - 1.93 % $ 17.4 M usaUSA
Brickell Biotech Brickell Biotech
BBI
254 - -5.38 % $ 6.06 M usaUSA
CytomX Therapeutics CytomX Therapeutics
CTMX
12.2 $ 4.22 -0.47 % $ 582 M usaUSA
Calithera Biosciences Calithera Biosciences
CALA
28.8 - -10.95 % $ 876 K usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
154 - - $ 2.17 B usaUSA
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCC
185 - -5.98 % $ 34.1 M usaUSA